MedTrace Logo

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

NCT03793348 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-01-04

No results posted yet for this study

Summary

Study evaluating the efficacy of a micro coring device for the treatment of moderate to severe check wrinkles

Conditions

  • Wrinkle

Interventions

DEVICE

MCD

Micro coring skin removal with automated coring device

Sponsors & Collaborators

  • Cytrellis Biosystems, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-12
Primary Completion
2019-06-15
Completion
2019-08-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793348 on ClinicalTrials.gov